Rapid and ultra-rapid metabolizers with CYP2C19*17 polymorphism do not respond to standard therapy with proton pump inhibitors.
about
CYP2C19*17 protects against metabolic complications of clozapine treatment.Complications of Psychotropic and Pain Medications in an Ultrarapid Metabolizer Patient at the Upper 1% of Cytochrome P450 (CYP450) Function Quantified by Combinatorial CYP450 Genotyping.Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine.
P2860
Rapid and ultra-rapid metabolizers with CYP2C19*17 polymorphism do not respond to standard therapy with proton pump inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Rapid and ultra-rapid metaboli ...... y with proton pump inhibitors.
@en
type
label
Rapid and ultra-rapid metaboli ...... y with proton pump inhibitors.
@en
prefLabel
Rapid and ultra-rapid metaboli ...... y with proton pump inhibitors.
@en
P2093
P2860
P1433
P1476
Rapid and ultra-rapid metaboli ...... y with proton pump inhibitors.
@en
P2093
Manu Tandan
Murthy H V V
Nageshwar Reddy D
Neha Deshpande
Ravi Kanth V V
Rupa Banerjee
Sasikala M
Sharanya V
P2860
P304
P356
10.1016/J.MGENE.2016.06.004
P577
2016-06-18T00:00:00Z